Searchable abstracts of presentations at key conferences in endocrinology

ea0099p286 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

The clock regulator bmal1 mediates the circadian control of gc-dependent skeletal muscle catabolism by driving PI3K (P100α)-GR interaction

Negri Mariarosaria , Pivonello Claudia , Amatrudo Feliciana , Patalano Roberta , Paola Provvisiero Donatella , de Angelis Cristina , Larocca Angelica , Simeoli Chiara , Colao Annamaria , Pivonello Rosario

The transcriptional activator Bmal1, reaching acrophase in the morning and bathyphase in the evening, is the main regulator of circadian clock. A mutual interaction between circadian clock and glucocorticoids (GCs) has been described as well as their implication in muscle metabolism. The current in vitro study aims at investigating Bmal1 involvement in muscle catabolism induced by GCs circadian exposure. To this aim, mouse myocytes C2C12 were serum-shocked to synchron...

ea0099p107 | Pituitary and Neuroendocrinology | ECE2024

Circulating levels of mir-375 in cushing’s disease patients and evaluation of its role in the regulation of sstr2 expression in murine pituitary corticotroph tumor cell model

Pivonello Claudia , Patalano Roberta , Monto Tatiana , Negri Mariarosaria , Amatrudo Feliciana , Provvisiero Donatella , Simeoli Chiara , Di Paola Nicola , Larocca Angelica , Crescenzo Erminio , Colao Annamaria , Pivonello Rosario

In vitro studies suggest that glucocorticoids (GC) long-term exposure downregulates SSTR2 but not SSTR5 expression in human and mouse ACTH-secreting tumor cells (AtT20), limiting the efficacy of octreotide (OCT), a somatostatin-receptor ligand with high affinity for SSTR2, in the treatment of Cushing’s disease (CD). In AtT20, dexamethasone treatment increased miR-375 expression, whose analysis revealed a seed-sequence for SSTR2, supporting the hypothesis that exc...

ea0099p521 | Pituitary and Neuroendocrinology | ECE2024

Assessing long-term safety and efficacy of osilodrostat in prior- and new-use patients with endogenous cushing’s syndrome: a 1-year real-world interim analysis of the non-interventional, multinational LINC 6 study

Castinetti Frederic , Geer Eliza , Biller Beverly , Feelders Richard , Fleseriu Maria , Pivonello Rosario , Reincke Martin , Tabarin Antoine , Le Mouhaer Jeannie , Stermenska Julia , Maldonado Mario , Bancos Irina

Introduction: Potent 11β-hydroxylase inhibitor osilodrostat provides cortisol level control in patients with Cushing’s syndrome (CS), as demonstrated by the LINC clinical development programme in Cushing’s disease (CD) patients.1 We report data from year 1 of the prospective observational LINC6 study (NCT05382156), evaluating long-term safety and efficacy of osilodrostat in CS patients during 3 years of routine clinical practice.<p class="abstext"...

ea0099p402 | Late-Breaking | ECE2024

Gonadis national registry on gonadal status in pituitary and adrenal disorders: prevalence and characterization of testicular morpho-structural and reproductive alterations in male patients with congenital adrenal hyperplasia

Menafra Davide , Ferrari Davide , Rastrelli Giulia , de Angelis Cristina , Minnetti Marianna , Simeoli Chiara , Vignozzi Linda , Corona Giovanni , Isidori Andrea , Pivonello Rosario

Congenital adrenal hyperplasia (CAH) is a disorder due to mutations of genes coding for adrenal steroidogenesis enzymes, commonly caused by 21α-hydroxylase enzyme deficiency. Severe impairment of 21α-hydroxylase synthesis results in the classic form of CAH (c-CAH) characterized by cortisol and aldosterone deficiency (salt wasting form - SW), or partial enzyme deficiency characterized by cortisol deficiency (simple virilizing form - SV); mild impairment of 21α-hy...

ea0099ep413 | Adrenal and Cardiovascular Endocrinology | ECE2024

Modified release hydrocortisone, a new treatment for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a single center ‘real-world evidence’ preliminary study

Simeoli Chiara , M. Crescenzo Erminio , M. Pulci Doria Augusta , Larocca Angelica , Di Paola Nicola , Pivonello Claudia , Negri Mariarosaria , Colao Annamaria , Pivonello Rosario

Life-long glucocorticoid (GC) treatment is needed in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, to replace GC deficiency and to control androgens excess. Multiple daily immediate-release-hydrocortisone (IR-HC), characterized by GC overexposure, peaks and troughs, is frequently associated with a suboptimal androgen control, due to ACTH overnight increase. Once daily dual-release-HC (DR-HC), approved for adrenal insufficiency and, despit...

ea0099ep269 | Pituitary and Neuroendocrinology | ECE2024

Disentangling glucose metabolism during and after pregnancy in women with chronic hyperprolactinemia

Roberta Scairati , Simona Auriemma Renata , Di Meglio Sara , Del Vecchio Guendalina , Pirchio Rosa , Graziadio Chiara , Pivonello Claudia , Pivonello Rosario , Colao Annamaria

Context: Prolactin (PRL) exerts a crucial role in the regulation of mammalian reproduction and in the promotion of lactation as response to the suckling reflex. Beyond this, it directly modulates gluco-insulinemic metabolism.ObjectiveTo dissect glucose metabolism during and after pregnancy in patients with chronic hyperprolactinemia (CTPE).MethodsThis longitudinal study included 52 reproductive aged women with CTPE due to pituitary adenomas (43 microadenomas, 9 macroadenomas),...

ea0099ep467 | Pituitary and Neuroendocrinology | ECE2024

Morphology and function of reproductive system in women with hyperprolactinemia in chronic treatment with cabergoline

Del Vecchio Guendalina , Scairati Roberta , Gallo Fabiana , Pirchio Rosa , Di Meglio Sara , Carbone Luigi , Alviggi Carlo , Colao Annamaria , Pivonello Rosario , Simona Auriemma Renata

Purpose: The present study aimed at investigating the morphology and function of reproductive system in women with hyperprolactinemia (HPRL) receiving chronic treatment with cabergoline (CAB)Methods: Twenty-three women(aged 34.21&pm;10.09 yrs) with HPRL, including 17 with microprolactinoma, 3 with macroprolactinoma and 3 with iatrogenic HPRL, entered the study. All patients were well-controlled with CAB treatment (medium dose 0.46&pm;0.45 mg/week). In po...

ea0099ep1009 | Reproductive and Developmental Endocrinology | ECE2024

Female sexual function in pregnancy: impact of gluco-metabolic profile, vitamin D status and chronotype

Scairati Roberta , Simona Auriemma Renata , Graziadio Chiara , Del Vecchio Guendalina , Verde Nunzia , Muscogiuri Giovanna , Di Spiezio Attilio , Colao Annamaria , Pivonello Rosario

Rationale: The gluco-metabolic changes during pregnancy significantly impact women’s sexual behavior. This study aimed to define the relationship between metabolic health and sexual function, along with human circadian rhythms and sleep quality during pregnancy.Methods: This study included 57 pregnant women (14 evaluated at first trimester, G1; 18 at second trimester, G2, and 25 at third trimester, G3). Among groups, no difference between age, gesta...

ea0099ep1250 | Late Breaking | ECE2024

Gonadis national registry on gonadal status in pituitary and adrenal disorders: prevalence and characterization of sexual dysfunctions in male patients with acromegaly

Garifalos Francesco , Feola Tiziana , Fralassi Noemi , De Angelis Cristina , Minnetti Marianna , Pirchio Rosa , Vignozzi Linda , Colao Annamaria , Corona Giovanni , Isidori Andrea , Pivonello Rosario

The potential independent role of growth hormone (GH) excess in sexual dysfunction of acromegalic male patients is poorly characterized. The aim of the current study was to evaluate the sexual function, in adult males with acromegaly, stratifying the cohort in “uncontrolled” and “controlled” disease. Data were retrieved from GONADIS, a national registry on gonadal status and reproductive and psycho-sexual function in patients affected by pituitary and adren...

ea0099ep1293 | Late Breaking | ECE2024

The impact of metabolic and hormonal alterations on sexual and psychological function in women with polycystic ovary syndrome

Verde Nunzia , Sorice Federica , Scairati Roberta , de Angelis Cristina , Garifalos Francesco , Menafra Davide , de Fraia Antonio , Santella Luigi , Mazzarella Alessandro , Simona Auriemma Renata , Colao Annamaria , Pivonello Rosario

The current study evaluated the impact of metabolic and hormonal alterations on sexual and psychological function in women with Polycystic Ovary Syndrome (PCOS). Fifty consecutive women aged 24.16&pm;5.97 years with a diagnosis of PCOS were recruited; metabolic and hormonal parameters were measured and questionnaires related to sexual function (Female Sexual Function Index-FSFI) and psychological traits (Middlesex Hospital Questionnaire-MHQ, Body Uneasiness Test A and B-BUT A ...